JP Morgan Maintains Overweight on Omada Health, Lowers Price Target to $25

Benzinga · 2d ago
JP Morgan analyst Lisa Gill maintains Omada Health (NASDAQ:OMDA) with a Overweight and lowers the price target from $30 to $25.